View Full Version : BECON 2001 Symposium

Mark Brown
03-19-2001, 05:03 AM
The National Institutes of Health (NIH) Bioengineering Consortium (BECON)
will convene a symposium titled "Reparative Medicine: Growing Tissues and
Organs" on June 25-26, 2001, at the Natcher Conference Center on the NIH
main campus in Bethesda, Maryland. This is the fourth in a series of annual
symposia sponsored by BECON. The symposium's intramural co-chairs are Dr.
Christine Kelley of the National Heart, Lung, and Blood Institute and Dr.
Loré Anne McNicol of the National Eye Institute.
The 2001 symposium will be comprised of a keynote address, 6 plenary talks,
10 breakout sessions, as well as posters and exhibits. The topics to be
covered will encompass the use of components of the body, such as genes,
proteins, and cells, to either foster tissue regeneration and remodeling in
vivo for the purpose of repairing, replacing, maintaining, or enhancing
organ function, or to engineer functional tissues in vitro for implantation
in vivo as a biological substitute for damaged or diseased tissues and

The NIH BECON symposium seeks to achieve a better understanding of this
exciting field, communicate new developments, and explore future research
possibilities to ensure that the NIH is poised to facilitate biomedical
research incorporating reparative medicine concepts and tools.
More specifically, the purposes of this symposium are as follows:
For the NIH:
Develop a vision for reparative medicine.
Identify the challenges and opportunities in reparative medicine.
Generate short- and long-term research needs and strategic goals.
Recommend the means to address research needs and to achieve goals.
For the Investigator:
Provide a forum to exchange knowledge.
Identify collaborators for future research.
For the Community:
Educate the community in the state of the science.
Disseminate information through a Web-based publication.


The symposium will provide unique opportunities for interdisciplinary
exchange through plenary talks, posters, exhibits, and breakout group
discussions. There will be ample time for discussion, and participants will
have the opportunity to explore new collaborations that may shape the next
generation of reparative medicine research, concepts, and tools.

General topics to be covered during the symposium include:

*Angiogenesis and Vascular Remodeling
*Biomaterials/Scaffolds for Tissue Repair
*Bioreactors and Bioprocessing
*Cells for Repair
*Functional Assessment of Engineered Tissues and
Elements of Tissue Design
*Genetic Approaches to Tissue Repair
*Immune Response to Engineered Tissues and Cells
*In Vivo Remodeling
*Molecular Signing
*Storage and Translational Issues in Reparative Medicine

These topics indicate the scope of reparative medicine and its potential
applications. As planning for the symposium continues and scientific
discussions begin, additional areas of relevance undoubtedly will surface.
These conversations and the recommendations that will emerge from the
symposium will help guide the NIH in creating new initiatives in this
exciting and important research area.
For more information on BECON 2001, and to register for the symposium,
please visit the symposium Web site,

Mark Brown, CMP
MasiMax Resources, Inc.

To unsubscribe send SIGNOFF BIOMCH-L to LISTSERV@nic.surfnet.nl
For information and archives: http://isb.ri.ccf.org/biomch-l